Patients with advanced cancer prefer open, effective communication
the ONA take:
A majority of patients with advanced cancer in a Japanese population study preferred that their physicians be realistic about their future and be reassured that painful symptoms would be controlled. The study was published online ahead of print in Cancer.
Additionally, patients who had cancer at certain sites, those who were recently diagnosed, as well as those with children, believed that their physicians should effectively communicate their prospects specific to their individual needs.
Researchers led by Shino Umezawa, MS, RN, of Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences looked at 106 patients with cancer who were informed at least one week prior to cessation of their anti-cancer treatment.
Patients were asked to fill out a survey on how they preferred communication regarding the end of their anticancer treatment and transitioning to palliative care.
The researchers found upon descriptive analysis that patients strongly preferred physicians to listen to their distress and concerns (96%), to assure them that painful symptoms would be controlled (97.1%) and to explain the status of their illness and any symptoms that would likely occur in the future (95.1%).
Upon multiple regression analyses to determine the factors associated with these preferences, the researchers found that telling patients to prepare mentally and informing them of their life expectancy was associated with cancer site, sustaining hope was associated with cancer site and children, and empathic paternalism was associated with duration since cancer diagnosis.
A majority of patients with advanced cancer preferred that their physicians be realistic about their future.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|